Enverdis is Monitoring Equipment in Germany that focus on cardiogoniometry system business. Founded in 1997. They cover business area such as developer, medical technology product, Acute Coronary Syndrome, cardiologic explorer, electrocardiography, cardiogoniometry, system, identification, myocardial ischemia, detection, perfusion malfunction, late enhancement, people, hypertension, arteriosclerotic vascular lesion.
1997
( 27 years old in 2024 )
Cardiogoniometry System
-
Furstenwall 63
40219 Dusseldorf
Germany
Private
developermedical technology productAcute Coronary Syndromecardiologic explorerelectrocardiographycardiogoniometrysystemidentificationmyocardial ischemiadetectionperfusion malfunctionlate enhancementpeoplehypertensionarteriosclerotic vascular lesion
* We use standard office opening hours in near Enverdis's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Enverdis is Monitoring Equipment business from Germany that founded in 1997 (27 years old in 2024), Enverdis business is focusing on Cardiogoniometry System.
Enverdis headquarter office and corporate office address is located in Furstenwall 63 40219 Dusseldorf Germany.
Enverdis was founded in Germany.
In 2024, Enverdis is currently focus on cardiogoniometry system sector.
Above is snippet of Google Trends for "cardiogoniometry system" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Enverdis, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.